FY25 results webcast to take place on Friday, 27 March 2026 at 3pm CET Louvain-la-Neuve, Belgium, 13 March 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, announces today that it will publish its consolidated results for the full year 2025 on Friday, 27 March 2026 at 7am CET. Conference Call Information IBA’s management team will host team will host a conference call and webcast conducted in English to present the half year results, followed by a Q&A session. The conference call will be held on Friday, 27 March 2026 at 3pm CET / 2pm BST / 10am EDT / 7am PDT as a Teams webinar. To attend the webcast, register via this link. The presentation will be available on IBA’s investor relations website and on: https://www.iba-worldwide.com/iba-full-year-2025-results-press-release-conference-call...

Kyivstar Group Ltd (“Kyivstar,” the “Group”) FY25 and 4Q25 results highlightsTotal revenue for FY25 grew 25.9% to USD 1,157 mn (30.3% to UAH 48.2 bn) year-on-year (“YoY”). 4Q25 revenue increased 28.4% to USD 321 mn (30.1% to UAH 13.5 bn) YoY. EBITDA for FY25 rose 25.8% to USD 648 mn (30.0% to UAH 27.0 bn) with an EBITDA margin of 56.0%. In 4Q25, EBITDA increased 21.7% to USD 172 mn (23.1% YoY to UAH 7.2 bn) with the EBITDA margin at 53.5%. Adjusted net profit was USD 289 mn for FY25, with earnings per share of USD 1.32. Unadjusted net profit was USD 124 mn, EPS USD 0.57, the differences from adjusted numbers resulting from the USD 162 mn non-cash charge related to the Kyivstar listing in 3Q25. Unadjusted net profit for 4Q25 was USD 90 mn. Digital revenue grew 4.7x in FY25 to USD 124 mn (4.9x to UAH 5.2 bn), reaching 10.7% of the revenue...

VEON Delivers Record Digital Growth: 4Q25 Digital Revenues Grow 84% to 20.1% of Total, Driving 17% Revenue and 29% EBITDA Growth in 4Q25 Dubai and New York, March 13, 2026 – VEON Ltd. (NASDAQ: VEON), a global digital operator, today announced strong financial and operating results for the fourth quarter and full year ended December 31, 2025. Key Highlights – Fourth Quarter 2025Total revenue grew 17.4% year-on-year (“YoY”) to USD 1,171 million. EBITDA increased 29.1% YoY to USD 527 million, with EBITDA margin expanding 410 bps to 45.0%. Digital revenues grew 84.1% YoY to USD 235 million, accounting for 20.1% of Group revenue. Financial services revenues rose 28.1% YoY to USD 120 million.Key Highlights – Full Year 2025Total revenue increased 9.9% YoY to USD 4,399 million. EBITDA rose 18.8% YoY to USD 2,009 million, with EBITDA margin...

VANCOUVER, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) — Tree Island Steel (“Tree Island” or the “Company”) (TSX: TSL) today reported its financial results for the year ended December 31, 2025. For the three-month period ended December 31, 2025, revenues, net of freight and distribution, were $32.4 million, compared with $44.8 million in the same period last year. The decline primarily reflected lower U.S. sales volumes due to the ongoing impact of expanded U.S. tariffs on wire and wire products, as well as the Company’s strategic withdrawal from certain unprofitable product lines. These factors were partially offset by continued growth in Canadian sales, consistent with the Company’s increased focus on domestic markets. For the full year, revenues totaled $161.8 million, down from $207.0 million in 2024. Despite higher average...

TORONTO, March 12, 2026 (GLOBE NEWSWIRE) — Firm Capital Mortgage Investment Corporation (the “Corporation”) (TSX FC, FC.DB.J, FC.DB.K ,FC.DB.L and FC.DB.M) today released its financial statements for the three and twelve months ended December 31, 2025. NET INCOME For the three months ended December 31, 2025, net income decreased by 4.7% to $8,735,874 as compared to $9,164,362 for the same period in 2024. Net income for the year ended December 31, 2025, increased by 6.4% to $37,471,563, as compared to $35,228,450 reported for the same period in 2024. EARNINGS PER SHARE Basic weighted average earnings per share for the three months ended December 31, 2025 was $0.238, as compared to the $0.249 per share reported for the three months ended December 31, 2024. Basic weighted average earnings per share for the year ended December 31, 2025...

VICTORIA, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today announced its financial results for the fourth quarter of 2025. All dollar values are in U.S. dollars unless stated otherwise. “2025 was a pivotal year for Eupraxia. We achieved significant clinical milestones in the development of our lead program, EP-104GI, and strengthened our balance sheet with two recent financings, positioning us well for our next phase of growth” said James Helliwell, CEO of Eupraxia. “As we look ahead to an exciting year, we anticipate multiple clinical readouts...

VANCOUVER, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) — Central 1 Credit Union (Central 1) today reported fourth quarter and year-end 2025 performance ahead of expectations. “With solid financial performance providing a strong foundation, 2025 gave us the clarity to accelerate transformative change across our organization,” says Sheila Vokey, Central 1’s President & CEO. “This year marked a defining turning point for Central 1 as we advanced our strategy, strengthened our governance, and deepened client partnerships to shape Central 1 as an agile, future-ready national leader in payments and treasury services.” Fourth quarter 2025 compared with fourth quarter 2024:Net income was $9.7 million, compared with $16.3 million Adjusted net income¹ was $9.2 million, compared with $25.7 million Net interest income was $19.8...

CALGARY, Alberta, March 12, 2026 (GLOBE NEWSWIRE) — Bonterra Energy Corp. (TSX: BNE; OTCID: BNEFF) (“Bonterra” or the “Company”) is pleased to announce its financial and operating results for the fourth quarter and year ended December 31, 2025, achieving a record annual production, together with highlights of an independent oil and gas reserves evaluation (the “Sproule Report”) prepared by Sproule International Limited (“Sproule”), effective December 31, 2025. The related financial statements and notes, as well as management’s discussion and analysis along with the annual information form for the period ended December 31, 2025, are available on SEDAR+ www.sedarplus.ca and on our website www.bonterraenergy.com.Record annual production of 15,513 BOE per day, exceeding revised guidance and representing a 5% increase from the prior...

TONMYA™ (cyclobenzaprine HCl sublingual tablets) launched November 17, 2025, for the treatment of fibromyalgia; through February 27, 2026, more than 1,500 healthcare providers have prescribed TONMYA to patients, approximately 2,500 patients have initiated treatment with TONMYA, and cumulative prescriptions totaled approximately 4,200 Expect to initiate U.S. field study in 2027 for TNX-4800 for seasonal prevention of Lyme disease pending FDA clearance Completed $20.0 million registered direct offering with Point72 on December 29, 2025 Approximately $207.6 million in cash and cash equivalents as of December 31, 2025 BERKELEY HEIGHTS, N.J., March 12, 2026 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, commercial biotechnology company,...

VANCOUVER, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) — Swiss Water Decaffeinated Coffee Inc. (TSX:SWP) (“Swiss Water” or “the Company”), a leading specialty coffee company and premium chemical-free coffee decaffeinator, today reported financial results for the three months and fiscal year ended December 31, 2025. All amounts are expressed in Canadian dollars unless otherwise stated. Fourth Quarter 2025 HighlightsQ4’25 processed volumes decreased 2% compared to Q4’24; Revenue of $66.0 million, an increase of 34% over Q4’24; Net income of $1.2 million, a decrease of $0.8 million compared to Q4’24; Adjusted EBITDA of $4.2 million, a decrease of $0.7 million or 14% compared to Q4’24; The NY’C’ coffee futures price for Arabica coffee remained volatile during Q4’25, peaking at US$4.23/lb in November. During Q4’25, the NY’C’...